Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von GlobeNewswire (Europe)

ZeitAktuelle NachrichtenRatingLeser
DoESCO Technologies Inc.: ESCO Reports Second Quarter Fiscal 2024 Results57St. Louis, May 09, 2024 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the second quarter ended March 31, 2024 (Q2 2024). Operating...
► Artikel lesen
DoAnaptysBio, Inc.: Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update87Enrollment ongoing for global Phase 2b trial to treat atopic dermatitis (AD) with ANB032, our BTLA agonist; reiterating top-line data anticipated by year-end 2024Enrollment ongoing for global Phase...
► Artikel lesen
DoEastman Kodak: Kodak Reports First-Quarter 2024 Financial Results45ROCHESTER, N.Y., May 09, 2024 (GLOBE NEWSWIRE) -- Eastman Kodak Company (NYSE: KODK) today reported financial results for the first quarter 2024. First-quarter 2024 highlights include: Consolidated...
► Artikel lesen
DoArtisan Partners Asset Management Inc. Reports April 2024 Assets Under Management26MILWAUKEE, May 09, 2024 (GLOBE NEWSWIRE) -- Artisan Partners Asset Management Inc. (NYSE: APAM) today reported that its preliminary assets under management ("AUM") as of April 30, 2024 totaled $155.7...
► Artikel lesen
DoSensus Healthcare, Inc.: Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold53Revenues of $10.7 million, compared with $3.4 million in the prior-year quarter; Adjusted EBITDA (a non-GAAP measure) of $3.0 million, compared with negative $2.7 million in the prior-year quarterLaunched...
► Artikel lesen
DoCanterbury Park Holding Corporation Reports First Quarter Results23SHAKOPEE, Minn., May 09, 2024 (GLOBE NEWSWIRE) -- Canterbury Park Holding Corporation ("Canterbury" or the "Company") (Nasdaq: CPHC), today reported financial results for the first quarter ended March...
► Artikel lesen
DoPhunware, Inc.: Phunware Reports Significant Improvement in First Quarter 2024 Financial Results43AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN) ("Phunware" or the "Company"), the leading provider of patented wayfinding and mobile engagement solutions that enables...
► Artikel lesen
DoSenti Biosciences, Inc.: Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights354- First patient dosing of SENTI-202, a first-in-class logic-gated treatment for acute myeloid leukemia ("AML"), on track for the second quarter of 2024 - SOUTH SAN FRANCISCO, Calif., May 09, 2024...
► Artikel lesen
DoHaynes International, Inc. Reports Second Quarter Fiscal 2024 Financial Results34Second quarter net revenues of $152.5 million with improving production momentum after last quarter's three week unplanned outage at the 4-high hot rolling mill in the Kokomo plant. This compares...
► Artikel lesen
DoINmune Bio, Inc.: INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update32BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology company focused on developing treatments that harness the patient's innate...
► Artikel lesen
DoRigetti Computing, Inc.: Rigetti Computing Reports First Quarter 2024 Financial Results239BERKELEY, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (Nasdaq: RGTI) ("Rigetti" or the "Company"), a pioneer in full-stack quantum-classical computing, today announced its financial...
► Artikel lesen
DoArray Technologies, Inc. Reports Financial Results for the First Quarter 2024 - Achieves record gross margin and $2.1 billion of executed contracts and awarded orders34First Quarter 2024 Highlights Revenue of $153.4 millionGross Margin of 35.9%Adjusted gross margin of 38.3%(1)Net loss to common shareholders of $11.3 millionAdjusted EBITDA(1) of $26.2 millionBasic...
► Artikel lesen
DoGetty Images, Inc.: Getty Images Reports First Quarter 2024 Results70Grew Active Annual Subscribers by 79% to 262,000Annual Subscription Revenue Rose to 55.4% of Total RevenueReaffirms Outlook with Expected Return to Topline Growth in 2024 NEW YORK, May 09, 2024 (GLOBE...
► Artikel lesen
DoBrilliant Earth, LLC: Brilliant Earth Reports First Quarter 2024 Results179Increased Total Orders by 13.7% and Repeat Orders by Over 20% Year-Over-YearIncreased First Quarter 2024 Gross Margin by 500 bps to 59.9%Generated GAAP Diluted EPS of $0.01 and Adjusted Diluted EPS...
► Artikel lesen
DoSienna Senior Living Inc. Reports Strong First Quarter 2024 Financial Results and Moves Forward with Redevelopment of Long-Term Care Home in Keswick, Ontario31MARKHAM, Ontario, May 09, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) today announced its financial results for the three months ended March 31, 2024....
► Artikel lesen
DoGyre Therapeutics, Inc.: Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update45Phase 3 clinical trial evaluating F351 for the treatment of CHB-associated liver fibrosis in the PRC remains on track with data anticipated by early 2025 U.S. IND submission to evaluate F351 for...
► Artikel lesen
DoTerrAscend Reports First Quarter 2024 Financial Results90Net Revenue of $80.6 million, an increase of 16.1% year-over-year Cash Flow from operations of $13.3 million and Free Cash Flow1 of $10.5 million in the quarter TORONTO, May 09, 2024 (GLOBE NEWSWIRE)...
► Artikel lesen
DoKarat Packaging Inc.: Karat Packaging Reports 2024 First Quarter Financial Results94CHINO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (Nasdaq: KRT) ("Karat" or the "Company"), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice...
► Artikel lesen
DoApplied Optoelectronics, Inc.: Applied Optoelectronics Reports First Quarter 2024 Results75SUGAR LAND, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access network products for the internet datacenter, cable broadband...
► Artikel lesen
DoAutoscope Technologies Corporation Announces Financial Results and Dividend Declaration18MINNEAPOLIS, May 09, 2024 (GLOBE NEWSWIRE) -- Autoscope Technologies Corporation (OTCQX: AATC) today announced results for its quarter ended March 31, 2024. The Board of Directors has authorized and...
► Artikel lesen
DoAnaptysBio, Inc.: Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)22All eight patients from GEMINI-1 who responded to a single intravenous (IV) imsidolimab dose and were subsequently re-randomized to monthly subcutaneous (SC) maintenance dosing of imsidolimab in GEMINI-2...
► Artikel lesen
DoAyala Pharmaceuticals Files Form 15 to Voluntarily Deregister and Suspend its Reporting Obligations91MONMOUTH JUNCTION, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that it filed a Form 15 with the Securities...
► Artikel lesen
DoFirst Quantum Minerals Ltd.: First Quantum Minerals Announces Voting Results for the Election of Directors201TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- First Quantum Minerals Ltd. ("First Quantum" or "the Company") (TSX: FM) announced that the nominees listed in the Management Information Circular for the 2024...
► Artikel lesen
DoOncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results20Fourth dosing cohort at 300 mg per day is fully enrolled for the Phase 1/2 study with ONCT-534, our dual-action androgen receptor inhibitor (DAARI), for patients with advanced prostate cancer who...
► Artikel lesen
DoNkarta, Inc.: Nkarta Reports First Quarter 2024 Financial Results and Corporate Highlights312Dosing of first patient with NKX019 for lupus nephritis using disease-tailored lymphodepletion expected in first half of 2024Cash balance of $450.0 million on March 31, 2024, including cash, cash...
► Artikel lesen